A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 60
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MAPKs
Long Form : MAP kinases
No. Year Title Co-occurring Abbreviation
2019 Dual-Specificity Phosphatases in Neuroblastoma Cell Growth and Differentiation. DUSPs, MKPs, NB
2019 Neuropeptide VGF-Derived Peptide LQEQ-19 has Neuroprotective Effects in an In Vitro Model of Amyotrophic Lateral Sclerosis. ALS, ERK
2018 Analysis of the thresholds for transcriptional activation by the yeast MAP kinases Fus3 and Kss1. ---
2017 Fingolimod Suppresses a Cascade of Core Vicious Cycle in Dry Eye NOD Mouse Model: Involvement of Sphingosine-1-Phosphate Receptors in Infiltrating Leukocytes. DED, MMPs, S1PRs
2017 Pathogen exploitation of an abscisic acid- and jasmonate-inducible MAPK phosphatase and its interception by Arabidopsis immunity. ABA, COR, ETI, JA, PP2Cs, Pto
2017 TGF-beta Stimulation of EMT Programs Elicits Non-genomic ER-alpha Activity and Anti-estrogen Resistance in Breast Cancer Cells. EMT, ERalpha, TGF-beta
2015 Mechanisms for proteinase-activated receptor 1-triggered prostaglandin E2 generation in mouse osteoblastic MC3T3-E1 cells. CREB, EGFR, MMP, PAR1, PGE2, PKC
2015 Muscarinic cholinoceptor-mediated activation of JNK negatively regulates intestinal secretion in mice. mAChR
2014 mTORC2 modulates feedback regulation of p38 MAPK activity via DUSP10/MKP5 to confer differential responses to PP242 in glioblastoma. DUSPs
10  2014 Targeting DUSPs in glioblastomas - wielding a double-edged sword? DUSPs, GBM
11  2013 ATR and MKP1 play distinct roles in response to UV-B stress in Arabidopsis. MKPs, UVB
12  2013 MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition. ERK, HD, JNKs
13  2013 MAP kinase phosphatase-3 (MKP-3) is transcriptionally and post-translationally up-regulated by hCG and modulates cAMP-induced p21 expression in MA-10 Leydig cells. LH, LHR, MKP-1, MKP-3
14  2013 The extraction of simple relationships in growth factor-specific multiple-input and multiple-output systems in cell-fate decisions by backward elimination PLS regression. IEGs, MIMO, PLS
15  2012 Citreorosein inhibits degranulation and leukotriene C₄ generation through suppression of Syk pathway in mast cells. 5-LO, BMMCs, CIT, P. cuspidati, PI3K, PLCgamma, SCF
16  2012 Ischemia-induced stimulation of cerebral microvascular endothelial cell Na-K-Cl cotransport involves p38 and JNK MAP kinases. BBB, NKCC
17  2012 Saucerneol F, a New Lignan Isolated from Saururus chinensis, Attenuates Degranulation via Phospholipase Cgamma 1 Inhibition and Eicosanoid Generation by Suppressing MAP Kinases in Mast Cells. 5-LO, BMMCs, COX-2, cPLA2, JNK, LTC4, PGD2, PLC-gamma1, S. chinensis, SF
18  2012 Therapeutic targets in the ASK1-dependent stress signaling pathways. ASK1, ER, JNKs, ROS
19  2011 Conjugated linoleic acid regulates phosphorylation of PPARgamma by modulation of ERK 1/2 and p38 signaling in human macrophages/fatty acid-laden macrophages. CLAs
20  2011 Dual-specificity MAP kinase phosphatases as targets of cancer treatment. DUSPs, MKPs, PTP
21  2011 MAPK phosphatase-1 (MKP-1) expression is up-regulated by hCG/cAMP and modulates steroidogenesis in MA-10 Leydig cells. CG, hCG, MKP-1
22  2011 Mitogen-activated protein kinase activity and reporter gene assays in plants. MAP
23  2011 Shigella flexneri type III secreted effector OspF reveals new crosstalks of proinflammatory signaling pathways during bacterial infection. TAK1
24  2011 Toll-like receptor 4 signaling is involved in IgA-stimulated mesangial cell activation. LPS, siRNA, TLR4
25  2010 Fibrocyte activation in rheumatoid arthritis. FLS, PB
26  2010 MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. 3'-UTR, IL-1beta, miR-27b, MMPs, mRNA, OA, PCR
27  2010 Signal transduction pathways associated with ATP-induced proliferation of colon adenocarcinoma cells. ATP, MKP-1
28  2009 A one-step method to identify MAP kinase residues involved in inactivation by tyrosine- and dual-specificity protein phosphatases. PPs, PTPs
29  2009 Extracellular ATP activates MAP kinase cascades through a P2Y purinergic receptor in the human intestinal Caco-2 cell line. ---
30  2009 Regulation of JNK and p38 MAPK in the immune system: signal integration, propagation and termination. MKPs
31  2009 The hydroxyflavone, fisetin, suppresses mast cell activation induced by interaction with activated T cell membranes. ICAM-1, RT
32  2009 Trans-Zeatin inhibits UVB-induced matrix metalloproteinase-1 expression via MAP kinase signaling in human skin fibroblasts. ECM, HSFs, MMP-1, MMPs, UV
33  2008 Photic regulation of map kinase phosphatases MKP1/2 and MKP3 in the hamster suprachiasmatic nuclei. MEKs, SCN
34  2007 Characterization of a novel low-molecular-mass dual specificity phosphatase-4 (LDP-4) expressed in brain. DSPs, LDP-4, LDP-4
35  2007 Dissecting the signaling pathway of nicotine-mediated neuroprotection in a mouse Alzheimer disease model. AD
36  2007 Ergosterol peroxide from an edible mushroom suppresses inflammatory responses in RAW264.7 macrophages and growth of HT29 colon adenocarcinoma cells. HMGCR, LDLR, ROS
37  2007 Regulatory mechanisms of mitogen-activated kinase signaling. ---
38  2006 Effects of interleukins 2 and 12 on TBT-induced alterations of MAP kinases p38 and p44/42 in human natural killer cells. TBT
39  2006 Measuring MAP kinase activity in immune complex assays. MAP
40  2005 Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases. TCR
41  2005 Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats. Ex-4, Ex-9, GLP-1, p70S6K, PI3K, PKB, PKC
42  2005 Fasudil hydrochloride hydrate, a Rho-kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells. alpha-SMA, HSCs, JNK, MMP-1, TIMP-1
43  2004 Anisomycin superinduces annexin V mRNA expression through the ERK1/2 but not the p38 MAP kinase pathway. ---
44  2004 Mos mediates the mitotic activation of p42 MAPK in Xenopus egg extracts. ---
45  2004 Structure and regulation of MAPK phosphatases. DS-MKPs, NT
46  2004 The control of cell motility and epithelial morphogenesis by Jun kinases. JNK
47  2003 Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. CGRP
48  2003 Vascular smooth muscle cell activation by C-reactive protein. CRP, ERK, IL-6, iNOS, JNK, VSMC
49  2002 MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis. ERK, IPF, JNK
50  2001 Direct effects of tumor necrosis factor alpha (TNF-alpha) on murine skeletal muscle cell lines. Bimodal effects on protein metabolism. TNF-alpha
51  2001 Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions. CD, MAPKKs, MKPs
52  2001 Molecular 'palpation' of BPH: a tale of MAPK signalling? BPH
53  2001 Solution structure of ERK2 binding domain of MAPK phosphatase MKP-3: structural insights into MKP-3 activation by ERK2. MKPs
54  2000 Induction of erythroid differentiation by inhibition of Ras/ERK pathway in a friend murine leukemia cell line. DMSO, EPO
55  1999 Fus3p and Kss1p control G1 arrest in Saccharomyces cerevisiae through a balance of distinct arrest and proliferative functions that operate in parallel with Far1p. ---
56  1999 Gi-mediated activation of mitogen-activated protein kinase (MAPK) pathway by receptor mimetic basic secretagogues of connective tissue-type mast cells: bifurcation of arachidonic acid-induced release upstream of MAPK. AA, MAPK, PI3K, PTKs, PTX
57  1998 Raf and fibroblast growth factor phosphorylate Elk1 and activate the serum response element of the immediate early gene pip92 by mitogen-activated protein kinase-independent as well as -dependent signaling pathways. FGF, MAP, SRE
58  1997 [Molecular mechanism of cardiac hypertrophy and dysfunction]. Ang II, ET-1, MAPKK, Raf-1
59  1996 Angiotensin II mediates mechanical stress-induced cardiac hypertrophy. Ang II, MAPKK, Raf-1
60  1996 Molecular aspects of mechanical stress-induced cardiac hypertrophy. MAPKK, Raf-1